Lilly Immergluck to Case-Control Studies
This is a "connection" page, showing publications Lilly Immergluck has written about Case-Control Studies.
Connection Strength
0.351
-
Immergluck LC, Jain S, Ray SM, Mayberry R, Satola S, Parker TC, Yuan K, Mohammed A, Jerris RC. Risk of Skin and Soft Tissue Infections among Children Found to be Staphylococcus aureus MRSA USA300 Carriers. West J Emerg Med. 2017 Feb; 18(2):201-212.
Score: 0.115
-
Immergluck LC, Parker TC, Jain S, Laghaie E, Spandorfer P, Jerris RC, Bowen MD, Parashar UD, Cortese MM. Sustained Effectiveness of Monovalent and Pentavalent Rotavirus?Vaccines in Children. J Pediatr. 2016 05; 172:116-120.e1.
Score: 0.108
-
Cortese MM, Leblanc J, White KE, Jerris RC, Stinchfield P, Preston KL, Meek J, Odofin L, Khizer S, Miller CA, Buttery V, Mijatovic-Rustempasic S, Lewis J, Parashar UD, Immergluck LC. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011 Dec; 128(6):e1474-81.
Score: 0.080
-
Mohammed A, Immergluck L, Parker TC, Jain S, Leong T, Anderson EJ, Jerris RC. Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis. Vaccine. 2015 Oct 13; 33(42):5670-5677.
Score: 0.026
-
Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, V?zquez M. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 2013 Jul; 132(1):e25-33.
Score: 0.022